AGP Picks
View all

Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on September 23, 2026

Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Pycnogenol® Offers Clinically Backed Cognitive Support Across Generations
IRADIMED CORPORATION To Participate in the 5th Annual ROTH Healthcare Opportunities Conference
Palisade Bio Expands Global Phase 2b ASCENTRA-UC Program with Health Canada CTA Clearance
SciSparc: Subsidiary NeuroThera Highlights Enhancement of U.S. Patent Portfolio Through Collaboration with Clearmind Covering LSD, Ketamine and Ibogaine Combinations
Parexel Transforms Functional Service Provider (FSP) Model to Improve R&D Productivity and Enhance Post-Approval Product Lifecycle Services for Biopharmaceutical Companies
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
Monogram Health Appoints James Lim as Chief Technology Officer
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma
Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease
Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors
BioAro Launches AI-Assisted LONgevity+™ Bioactives in the U.S. and U.K.
PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures
Altimmune to Participate in Stifel Cardiometabolic Forum
Adaptyx Biosciences Granted FDA Breakthrough Device Designation For Its Continuous Cortisol Monitoring Technology and Is Accepted into FDA’s Total Product Life Cycle Advisory Program
Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations
Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health World Mauritania

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.